On the public citation graph
Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role of Signal Transducer and Activator of Transcription 3
0 signed · 466 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/hep.1840050212openalex-snapshot
Severe and Progressive Steatosis and Focal Necrosis in Rat Liver Induced by Continuous Intragastric Infusion of Ethanol and Low Fat Diet
inferredcites →https://doi.org/10.1002/hep.1840400424openalex-snapshot
Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease
inferredcites →https://doi.org/10.1002/hep.20184openalex-snapshot
Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation
inferredcites →https://doi.org/10.1002/hep.20206openalex-snapshot
A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis
inferredcites →https://doi.org/10.1002/hep.21138openalex-snapshot
Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver
inferredcites →https://doi.org/10.1002/hep.22222openalex-snapshot
Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice
inferredcites →https://doi.org/10.1002/hep.22470openalex-snapshot
The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88†
inferredcites →https://doi.org/10.1002/hep.22680openalex-snapshot
The interleukin-17 pathway is involved in human alcoholic liver disease # †
inferredcites →https://doi.org/10.1002/hep.22776openalex-snapshot
An early complement-dependent and TLR-4–independent phase in the pathogenesis of ethanol-induced liver injury in mice #
inferredcites →https://doi.org/10.1002/hep.22847openalex-snapshot
Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice #
inferredcites →https://doi.org/10.1002/hep.23090openalex-snapshot
Zinc Supplementation Reverses Alcohol-Induced Steatosis in Mice Through Reactivating Hepatocyte Nuclear Factor-4α and Peroxisome Proliferator-Activated Receptor-α†
inferredcites →https://doi.org/10.1002/hep.23382openalex-snapshot
Epigenetic Regulation of Hepatic Endoplasmic Reticulum Stress Pathways in the Ethanol-Fed Cystathionine Beta Synthase–Deficient Mouse
inferredcites →https://doi.org/10.1002/hep.23652openalex-snapshot
Comments on Aasld Practice Guidelines for Alcoholic Liver Disease
inferredcites →https://doi.org/10.1007/978-1-59745-242-7_3openalex-snapshot
Intragastric Ethanol Infusion Model in Rodents
inferredcites →https://doi.org/10.1007/s00109-009-0448-1openalex-snapshot
IL-22: A critical mediator in mucosal host defense
inferredcites →https://doi.org/10.1016/0300-483x(95)03128-3openalex-snapshot
Recombinant human interleukin-6: safety issues of a pleiotropic growth factor
inferredcites →https://doi.org/10.1016/j.jhep.2008.10.020openalex-snapshot
The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model
inferredcites →https://doi.org/10.1016/j.jhep.2010.03.004openalex-snapshot
Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22
inferredcites →https://doi.org/10.1038/ncpgasthep0683openalex-snapshot
Management strategies in alcoholic liver disease
inferredcites →https://doi.org/10.1053/j.gastro.2006.12.036openalex-snapshot
Hepatic Expression of Candidate Genes in Patients With Alcoholic Hepatitis: Correlation With Disease Severity
inferredcites →https://doi.org/10.1053/j.gastro.2008.01.016openalex-snapshot
Cell Type–Dependent Pro- and Anti-Inflammatory Role of Signal Transducer and Activator of Transcription 3 in Alcoholic Liver Injury
inferredcites →https://doi.org/10.1053/j.gastro.2008.08.057openalex-snapshot
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
inferredcites →https://doi.org/10.1053/j.gastro.2009.04.062openalex-snapshot
Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor
inferredcites →https://doi.org/10.1055/s-0029-1214373openalex-snapshot
“Second Hit” Models of Alcoholic Liver Disease
inferredcites →https://doi.org/10.1074/jbc.m803510200openalex-snapshot
Silencing of Hepatic Fatty Acid Transporter Protein 5 in Vivo Reverses Diet-induced Non-alcoholic Fatty Liver Disease and Improves Hyperglycemia
inferredcites →https://doi.org/10.1080/10915810490502069openalex-snapshot
Early-Phase Alcoholic Liver Disease: An Update on Animal Models, Pathology, and Pathogenesis
inferredcites →https://doi.org/10.1097/00000374-200105051-00041openalex-snapshot
Models of Alcoholic Liver Disease in Rodents: A Critical Evaluation
inferredcites →https://doi.org/10.1111/j.1530-0277.2001.tb02405.xopenalex-snapshot
Models of Alcoholic Liver Disease in Rodents: A Critical Evaluation
inferredcites →https://doi.org/10.1152/ajpgi.00056.2004openalex-snapshot
Recent Advances in Alcoholic Liver Disease II. Minireview: molecular mechanisms of alcoholic fatty liver
inferredcites →https://doi.org/10.1152/ajpgi.00075.2009openalex-snapshot
IL-22 is involved in liver regeneration after hepatectomy
inferredcites →https://doi.org/10.1152/ajpgi.00456.2009openalex-snapshot
Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice
inferredcites →https://doi.org/10.1152/ajpgi.1992.263.4.g579openalex-snapshot
Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy
inferredcites →https://doi.org/10.1177/153537020222700310openalex-snapshot
Metallothionein Protection against Alcoholic Liver Injury through Inhibition of Oxidative Stress
inferredcites →https://doi.org/10.1210/endo-102-4-1107openalex-snapshot
Suppression of Liver Cell Proliferation by Glucocorticoid Hormone: A Comparison of Normally Growing and Regenerating Tissue in the Immature Rat*
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9780470555293.ch11openalex-snapshot
Current Challenges and Future Directions
inferred← citeshttps://doi.org/10.1002/advs.202405781openalex-snapshot
Postbiotics From Lactobacillus Johnsonii Activates Gut Innate Immunity to Mitigate Alcohol‐Associated Liver Disease
inferred← citeshttps://doi.org/10.1002/cti2.1017openalex-snapshot
The role of IL ‐22 in the resolution of sterile and nonsterile inflammation
inferred← citeshttps://doi.org/10.1002/hep.24339openalex-snapshot
In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression
inferred← citeshttps://doi.org/10.1002/hep.26419openalex-snapshot
Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: A critical role for E-selectin
inferred← citeshttps://doi.org/10.1002/hep.26521openalex-snapshot
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis
inferred← citeshttps://doi.org/10.1002/hep.26596openalex-snapshot
Build a better mouse model, and the world will beat a path to your door
inferred← citeshttps://doi.org/10.1002/hep.26915openalex-snapshot
Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice
inferred← citeshttps://doi.org/10.1002/hep.26916openalex-snapshot
Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment
inferred← citeshttps://doi.org/10.1002/hep.27383openalex-snapshot
Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice
inferred← citeshttps://doi.org/10.1002/hep.27629openalex-snapshot
IL‐22 and IL‐22 binding protein (IL‐22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections
inferred← citeshttps://doi.org/10.1002/hep.27688openalex-snapshot
Interplay of interleukin‐22 and its binding protein in controlling liver scarring
inferred← citeshttps://doi.org/10.1002/hep.31046openalex-snapshot
An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis
inferred← citeshttps://doi.org/10.1002/hep4.1303openalex-snapshot
IL‐22 and IL‐22‐Binding Protein Are Associated With Development of and Mortality From Acute‐on‐Chronic Liver Failure
inferred← citeshttps://doi.org/10.1002/ibd.22929openalex-snapshot
Healing of intestinal inflammation by IL-22
inferred← citeshttps://doi.org/10.1002/jhbp.245openalex-snapshot
Recent advancement of molecular mechanisms of liver fibrosis
inferred← citeshttps://doi.org/10.1002/jlb.4a0122-068ropenalex-snapshot
IL-22 andLactobacillus delbrueckiimitigate alcohol-induced exacerbation of DSS-induced colitis
inferred← citeshttps://doi.org/10.1002/mco2.70063openalex-snapshot
Neutrophil heterogeneity and plasticity: unveiling the multifaceted roles in health and disease
inferred← citeshttps://doi.org/10.1002/mco2.70145openalex-snapshot
Carabrone Attenuates Metabolic Dysfunction–Associated Steatohepatitis by Targeting STAT3 in Mice
inferred← citeshttps://doi.org/10.1002/path.6002openalex-snapshot
Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC‐induced cholestatic injury by promoting a pro‐restorative inflammatory response
inferred← citeshttps://doi.org/10.1002/wsbm.1499openalex-snapshot
Liver fibrosis: Pathophysiology and clinical implications
inferred← citeshttps://doi.org/10.1007/978-1-0716-0704-6_15openalex-snapshot
Mouse Model of Alcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1007/978-3-030-51709-0_20openalex-snapshot
Alcohol-Associated Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-0348-0522-3_4openalex-snapshot
Contributions of IL-22 to TH17 Responses: Repairing and Protecting Peripheral Tissues
inferred← citeshttps://doi.org/10.1007/978-3-319-20538-0_15openalex-snapshot
Treatment of Alcoholic Liver Disease Including Emerging Therapies, Novel Targets, and Liver Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-319-98890-0_14openalex-snapshot
Animal Models When Examining the Gut-Liver Axis
inferred← citeshttps://doi.org/10.1007/978-4-431-54442-5_6openalex-snapshot
Interleukin-22: A Bridge Between Epithelial Innate Host Defense and Immune Cells
inferred← citeshttps://doi.org/10.1007/978-94-017-9487-9_8openalex-snapshot
The Biology and Functions of Th22 Cells
inferred← citeshttps://doi.org/10.1007/s00011-014-0727-3openalex-snapshot
Role of Interleukin-22 in liver diseases
inferred← citeshttps://doi.org/10.1007/s00011-023-01776-2openalex-snapshot
Pirfenidone ameliorates liver steatosis by targeting the STAT3-SCD1 axis
inferred← citeshttps://doi.org/10.1007/s00109-016-1391-6openalex-snapshot
Biological and pathological activities of interleukin-22
inferred← citeshttps://doi.org/10.1007/s00109-019-01808-7openalex-snapshot
S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver
inferred← citeshttps://doi.org/10.1007/s00281-021-00854-zopenalex-snapshot
The good and the bad about separation anxiety: roles of IL-22 and IL-22BP in liver pathologies
inferred← citeshttps://doi.org/10.1007/s10620-014-3473-zopenalex-snapshot
Cell Mediators of Autoimmune Hepatitis and Their Therapeutic Implications
inferred← citeshttps://doi.org/10.1007/s11901-025-00703-9openalex-snapshot
Alcohol-Associated Hepatitis: Translating Pathophysiology into Targeted Clinical Trials
inferred← citeshttps://doi.org/10.1007/s12016-012-8323-1openalex-snapshot
Immunological Orchestration of Liver Fibrosis
inferred← citeshttps://doi.org/10.1007/s12026-022-09325-5openalex-snapshot
Role of IL-22 in intestinal microenvironment and potential targeted therapy through diet
inferred← citeshttps://doi.org/10.1007/s12072-014-9516-xopenalex-snapshot
New drug targets for alcoholic liver disease
inferred← citeshttps://doi.org/10.1007/s12072-019-09950-7openalex-snapshot
Alteration of splicing factors’ expression during liver disease progression: impact on hepatocellular carcinoma outcome
inferred← citeshttps://doi.org/10.1007/s12072-020-10082-6openalex-snapshot
Interleukin-22 in alcoholic hepatitis and beyond
inferred← citeshttps://doi.org/10.1007/s12192-012-0375-xopenalex-snapshot
Tissue-specific upregulation of HSP72 in mice following short-term administration of alcohol
inferred← citeshttps://doi.org/10.1007/s12272-022-01392-4openalex-snapshot
Alcoholic liver disease: a new insight into the pathogenesis of liver disease
inferred← citeshttps://doi.org/10.1007/s12272-025-01537-1openalex-snapshot
Impact of binge drinking on alcoholic liver disease
inferred← citeshttps://doi.org/10.1007/s13277-015-4294-1openalex-snapshot
IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s40139-014-0053-zopenalex-snapshot
New Approaches for Studying Alcoholic Liver Disease
inferred← citeshttps://doi.org/10.1007/s40139-015-0088-9openalex-snapshot
Physiological and Pathological Properties of Interleukin-22 in Liver Diseases
inferred← citeshttps://doi.org/10.1007/s40139-017-0141-yopenalex-snapshot
Using Zebrafish to Model Liver Diseases-Where Do We Stand?
inferred← citeshttps://doi.org/10.1007/s43188-025-00289-wopenalex-snapshot
Advancing hepatotoxicity assessment: current advances and future directions
inferred← citeshttps://doi.org/10.1016/b978-0-12-800773-0.00005-7openalex-snapshot
Pathogenic Mechanisms in Alcoholic Liver Disease (ALD): Emerging Role of Osteopontin
inferred← citeshttps://doi.org/10.1016/b978-0-12-804214-4.00003-8openalex-snapshot
Cytokines in the Liver
inferred← citeshttps://doi.org/10.1016/b978-0-12-804274-8.00004-7openalex-snapshot
Autoimmune Hepatitis
inferred← citeshttps://doi.org/10.1016/b978-0-12-804274-8.00027-8openalex-snapshot
Cytokines in Hepatic Injury
inferred← citeshttps://doi.org/10.1016/b978-0-323-95488-4.00250-3openalex-snapshot
Hepatic Nonparenchymal Cells and Liver-Associated Lymphoid Cells
inferred← citeshttps://doi.org/10.1016/b978-0-323-98368-6.00012-4openalex-snapshot
Alcoholic hepatitis
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0268-8.00105-6openalex-snapshot
Ischemia-Reperfusion Injury in Liver Transplantation
inferred← citeshttps://doi.org/10.1016/b978-84-9113-949-2.00086-xopenalex-snapshot
10.1016/b978-84-9113-949-2.00086-x
inferred← citeshttps://doi.org/10.1016/j.ajpath.2012.06.013openalex-snapshot
Leptin Deficiency Contributes to the Pathogenesis of Alcoholic Fatty Liver Disease in Mice
inferred← citeshttps://doi.org/10.1016/j.ajpath.2012.08.043openalex-snapshot
Protective and Pathological Properties of IL-22 in Liver Disease
inferred← citeshttps://doi.org/10.1016/j.ajpath.2012.12.010openalex-snapshot
Application of Interleukin-22 Mediates Protection in Experimental Acetaminophen-Induced Acute Liver Injury
inferred← citeshttps://doi.org/10.1016/j.ajpath.2014.03.005openalex-snapshot
Adverse Signaling of Scavenger Receptor Class B1 and PGC1s in Alcoholic Hepatosteatosis and Steatohepatitis and Protection by Betaine in Rat
inferred← citeshttps://doi.org/10.1016/j.ajpath.2015.12.003openalex-snapshot
Murine Models of Acute Alcoholic Hepatitis and Their Relevance to Human Disease
inferred← citeshttps://doi.org/10.1016/j.ajpath.2025.03.010openalex-snapshot
An Update on IL-22 Therapies in Alcohol-Associated Liver Disease and Beyond
inferred← citeshttps://doi.org/10.1016/j.ajpath.2026.04.019openalex-snapshot
Complement C3a Receptor 1 and Complement C5a Receptor 1 Are Dual Contributors of Chronic-Plus-Binge–Induced Hepatic Inflammation and Injury
inferred← citeshttps://doi.org/10.1016/j.alcohol.2012.08.004openalex-snapshot
Rodent models of alcoholic liver disease: Of mice and men
inferred← citeshttps://doi.org/10.1016/j.alit.2018.10.002openalex-snapshot
Bidirectional roles of IL-22 in the pathogenesis of allergic airway inflammation
inferred← citeshttps://doi.org/10.1016/j.antiviral.2012.12.018openalex-snapshot
IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line
inferred← citeshttps://doi.org/10.1016/j.aohep.2020.06.010openalex-snapshot
STAT3: A key regulator in liver fibrosis
inferred← citeshttps://doi.org/10.1016/j.apsb.2026.09.019openalex-snapshot
Fucose utilization enhances the efficacy of Bacteroides thetaiotaomicron treatment on alcohol-associated liver disease in mice through regulating ILC3 function
inferred← citeshttps://doi.org/10.1016/j.archoralbio.2012.08.006openalex-snapshot
Expression of IL-22, IL-22R and IL-23 in the peri-implant soft tissues of patients with peri-implantitis
inferred← citeshttps://doi.org/10.1016/j.bbadis.2018.11.008openalex-snapshot
Effect of alcohol on the interleukin 6-mediated inflammatory response in a new mouse model of acute-on-chronic liver injury
inferred← citeshttps://doi.org/10.1016/j.bbalip.2016.07.012openalex-snapshot
SCD1 deficiency protects mice against ethanol-induced liver injury
inferred← citeshttps://doi.org/10.1016/j.bcp.2020.114323openalex-snapshot
Flightless-I is a potential biomarker for the early detection of alcoholic liver disease
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116334openalex-snapshot
PSTPIP2 protects against alcoholic liver injury and invokes STAT3-mediated suppression of apoptosis
inferred← citeshttps://doi.org/10.1016/j.bcp.2025.116785openalex-snapshot
Aryl hydrocarbon receptor (AHR) and nuclear factor erythroid-derived 2-like 2 (NRF2): An important crosstalk in the gut-liver axis
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2018.09.046openalex-snapshot
In vivo hepatocellular expression of interleukin-22 using penetratin-based hybrid nanoparticles as potential anti-hepatitis therapeutics
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2025.123623openalex-snapshot
A novel Kupffer cell-targeting nanoparticle system to Mitigate alcohol-associated liver disease
inferred← citeshttps://doi.org/10.1016/j.bioorg.2022.106034openalex-snapshot
Magnesium isoglycyrrhizinate ameliorates lipopolysaccharide-induced liver injury by upregulating autophagy and inhibiting inflammation via IL-22 expression
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113555openalex-snapshot
Recent advances in the therapeutic potential of emodin for human health
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.117163openalex-snapshot
Graveoline attenuates D-GalN/LPS-induced acute liver injury via inhibition of JAK1/STAT3 signaling pathway
inferred← citeshttps://doi.org/10.1016/j.cellsig.2019.109388openalex-snapshot
IL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential
inferred← citeshttps://doi.org/10.1016/j.cellsig.2022.110442openalex-snapshot
Indole-3-acetic acid improves the hepatic mitochondrial respiration defects by PGC1a up-regulation
inferred← citeshttps://doi.org/10.1016/j.celrep.2026.118085openalex-snapshot
Pectin alleviates alcohol-associated liver disease partly through cell-type-specific aryl hydrocarbon receptor signaling in female mice
inferred← citeshttps://doi.org/10.1016/j.cgh.2013.06.013openalex-snapshot
Alcoholic Hepatitis: Current Challenges and Future Directions
inferred← citeshttps://doi.org/10.1016/j.chom.2019.11.001openalex-snapshot
Roseburia spp. Abundance Associates with Alcohol Consumption in Humans and Its Administration Ameliorates Alcoholic Fatty Liver in Mice
inferred← citeshttps://doi.org/10.1016/j.chom.2023.02.001openalex-snapshot
Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease
inferred← citeshttps://doi.org/10.1016/j.cld.2012.08.003openalex-snapshot
Immunology in Alcoholic Liver Disease
inferred← citeshttps://doi.org/10.1016/j.cld.2016.02.004openalex-snapshot
Pathogenesis of Alcoholic Liver Disease
inferred← citeshttps://doi.org/10.1016/j.cld.2024.06.014openalex-snapshot
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis
inferred← citeshttps://doi.org/10.1016/j.clinre.2011.01.017openalex-snapshot
Mechanisms of the inflammatory reaction implicated in alcoholic hepatitis: 2011 update
inferred← citeshttps://doi.org/10.1016/j.clinre.2015.05.008openalex-snapshot
Combination therapy: New hope for alcoholic hepatitis?
inferred← citeshttps://doi.org/10.1016/j.clinre.2020.01.009openalex-snapshot
Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.cmet.2024.08.012openalex-snapshot
IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis
inferred← citeshttps://doi.org/10.1016/j.cnd.2014.12.002openalex-snapshot
Effets hépatiques de l’alcool
inferred← citeshttps://doi.org/10.1016/j.cyto.2011.07.022openalex-snapshot
Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice
inferred← citeshttps://doi.org/10.1016/j.cyto.2016.08.023openalex-snapshot
Role of Interleukin-22 in chronic liver injury
inferred← citeshttps://doi.org/10.1016/j.dld.2019.03.020openalex-snapshot
The role of sphingosine kinase 2 in alcoholic liver disease
inferred← citeshttps://doi.org/10.1016/j.ejphar.2026.179143openalex-snapshot
Drug repurposing of glucosamine to ameliorate alcoholic liver disease and delay liver aging through activation of AMPK signaling pathway
inferred← citeshttps://doi.org/10.1016/j.gtc.2011.06.008openalex-snapshot
Alcoholic Hepatitis: Prognostic Models and Treatment
inferred← citeshttps://doi.org/10.1016/j.heliyon.2017.e00458openalex-snapshot
Hepatic toxicity assessment of cationic liposome exposure in healthy and chronic alcohol fed mice
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e29853openalex-snapshot
The role of interleukin-20 in liver disease: Functions, mechanisms and clinical applications
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.124662openalex-snapshot
Dual-targeting galactose-functionalized hyaluronic acid modified lipid nanoparticles delivering silybin for alleviating alcoholic liver injury
inferred← citeshttps://doi.org/10.1016/j.intimp.2012.01.007openalex-snapshot
Discrepant roles of CpG ODN on acute alcohol-induced liver injury in mice
inferred← citeshttps://doi.org/10.1016/j.intimp.2013.06.012openalex-snapshot
Betulinic acid and betulin ameliorate acute ethanol-induced fatty liver via TLR4 and STAT3 in vivo and in vitro
inferred← citeshttps://doi.org/10.1016/j.intimp.2019.03.011openalex-snapshot
Carbenoxolone ameliorates hepatic lipid metabolism and inflammation in obese mice induced by high fat diet via regulating the JAK2/STAT3 signaling pathway
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.107327openalex-snapshot
Hepatoprotection by Ginsenoside Rg1 in alcoholic liver disease
inferred← citeshttps://doi.org/10.1016/j.isci.2024.109709openalex-snapshot
Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and de novo lipogenesis
inferred← citeshttps://doi.org/10.1016/j.jaut.2015.10.005openalex-snapshot
AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.101966openalex-snapshot
MicroRNA-200c coordinates HNF1 homeobox B and apolipoprotein O functions to modulate lipid homeostasis in alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2022.08.001openalex-snapshot
Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2023.05.010openalex-snapshot
In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2024.04.009openalex-snapshot
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
inferred← citeshttps://doi.org/10.1016/j.jep.2023.117552openalex-snapshot
A polysaccharide from Alhagi honey protects the intestinal barrier and regulates the Nrf2/HO-1-TLR4/MAPK signaling pathway to treat alcoholic liver disease in mice
inferred← citeshttps://doi.org/10.1016/j.jff.2017.03.059openalex-snapshot
Ganoderma lucidum repress injury of ethanol-induced steatohepatitis via anti-inflammation, anti-oxidation and reducing hepatic lipid in C57BL/6J mice
inferred← citeshttps://doi.org/10.1016/j.jgr.2014.09.001openalex-snapshot
Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activation
inferred← citeshttps://doi.org/10.1016/j.jhep.2012.01.029openalex-snapshot
STAT proteins – Key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver
inferred← citeshttps://doi.org/10.1016/j.jhep.2012.07.008openalex-snapshot
CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver
inferred← citeshttps://doi.org/10.1016/j.jhep.2014.05.024openalex-snapshot
Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury
inferred← citeshttps://doi.org/10.1016/j.jhep.2014.12.027openalex-snapshot
Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice
inferred← citeshttps://doi.org/10.1016/j.jhep.2015.08.023openalex-snapshot
RORγt+ IL-22-producing NKp46+ cells protect from hepatic ischemia reperfusion injury in mice
inferred← citeshttps://doi.org/10.1016/j.jhep.2016.11.008openalex-snapshot
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice
inferred← citeshttps://doi.org/10.1016/j.jhep.2018.11.005openalex-snapshot
Endpoints and patient stratification in clinical trials for alcoholic hepatitis
inferred← citeshttps://doi.org/10.1016/j.jhep.2020.04.011openalex-snapshot
Animal models for liver disease – A practical approach for translational research
inferred← citeshttps://doi.org/10.1016/j.jhep.2021.02.028openalex-snapshot
Alcohol-induced Hsp90 acetylation is a novel driver of liver sinusoidal endothelial dysfunction and alcohol-related liver disease
inferred← citeshttps://doi.org/10.1016/j.jhep.2026.01.016openalex-snapshot
IL-22 supports long-term expansion of mouse and human hepatocytes
inferred← citeshttps://doi.org/10.1016/j.jhep.2026.06.014openalex-snapshot
Hepatic-IL-22RA1 is indispensable for IL-22-induced in vitro expansion of primary mouse hepatocytes
inferred← citeshttps://doi.org/10.1016/j.jlr.2025.100898openalex-snapshot
Advanced alcoholic liver disease driven by a proferroptotic diet
inferred← citeshttps://doi.org/10.1016/j.jmu.2016.08.010openalex-snapshot
Alcoholic Liver Disease in the Asian–Pacific Region with High Prevalence of Chronic Viral Hepatitis
inferred← citeshttps://doi.org/10.1016/j.jnutbio.2016.08.011openalex-snapshot
Evaluating the effects of refined carbohydrate and fat diets with acute ethanol consumption using a mouse model of alcoholic liver injury
inferred← citeshttps://doi.org/10.1016/j.jnutbio.2021.108852openalex-snapshot
A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD+ metabolism upon alcohol withdrawal
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118678openalex-snapshot
Contribution of glutaredoxin-1 to Fas s-glutathionylation and inflammation in ethanol-induced liver injury
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119328openalex-snapshot
A review on molecular mechanism of alcoholic liver disease
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.120180openalex-snapshot
Interleukin-9 attenuates inflammatory response and hepatocyte apoptosis in alcoholic liver injury
inferred← citeshttps://doi.org/10.1016/j.lfs.2025.124151openalex-snapshot
NIK suppresses AKT/ACLY pathway-mediated lipogenesis in liver by stabilizing INPP5B during chronic ethanol exposure
inferred← citeshttps://doi.org/10.1016/j.livres.2017.09.003openalex-snapshot
Interleukin-22 in the pathogenesis and potential treatment of liver diseases
inferred← citeshttps://doi.org/10.1016/j.livres.2017.10.001openalex-snapshot
WITHDRAWN: IL-22 in liver inflammation, injury and repair
inferred← citeshttps://doi.org/10.1016/j.livres.2017.12.004openalex-snapshot
Targeting the gut barrier for the treatment of alcoholic liver disease
inferred← citeshttps://doi.org/10.1016/j.livres.2018.02.005openalex-snapshot
WITHDRAWN: Rodent models of fatty liver diseases
inferred← citeshttps://doi.org/10.1016/j.livres.2018.03.001openalex-snapshot
Rodent models of fatty liver diseases
inferred← citeshttps://doi.org/10.1016/j.livres.2018.11.002openalex-snapshot
Alcoholic liver disease: A current molecular and clinical perspective
inferred← citeshttps://doi.org/10.1016/j.livres.2019.04.002openalex-snapshot
Functions of hepatic non-parenchymal cells in alcoholic liver disease
inferred← citeshttps://doi.org/10.1016/j.livres.2024.06.002openalex-snapshot
Role of immune cell interactions in alcohol-associated liver diseases
inferred← citeshttps://doi.org/10.1016/j.molmet.2017.08.004openalex-snapshot
Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
inferred← citeshttps://doi.org/10.1016/j.molmet.2024.101965openalex-snapshot
Lipid-encapsulated mRNA encoding an extended serum half-life interleukin-22 ameliorates metabolic disease in mice
inferred← citeshttps://doi.org/10.1016/j.nut.2022.111888openalex-snapshot
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters
inferred← citeshttps://doi.org/10.1016/j.pan.2018.02.014openalex-snapshot
Diverse effects of interleukin-22 on pancreatic diseases
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2017.06.007openalex-snapshot
Targeting inflammation for the treatment of alcoholic liver disease
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2020.107752openalex-snapshot
Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2023.108353openalex-snapshot
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.plipres.2018.04.002openalex-snapshot
STAT3: The art of multi-tasking of metabolic and immune functions in obesity
inferred← citeshttps://doi.org/10.1016/j.redox.2024.103386openalex-snapshot
Chronic alcohol consumption aggravates acute kidney injury through integrin β1/JNK signaling
inferred← citeshttps://doi.org/10.1016/j.taap.2016.08.012openalex-snapshot
Chronic plus binge ethanol exposure causes more severe pancreatic injury and inflammation
inferred← citeshttps://doi.org/10.1016/j.taap.2024.117050openalex-snapshot
Integrated network toxicology, transcriptomics and gut microbiomics reveals hepatotoxicity mechanism induced by benzo[a]pyrene exposure in mice
inferred← citeshttps://doi.org/10.1016/j.toxlet.2015.11.019openalex-snapshot
Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances T reg and T H 17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding
inferred← citeshttps://doi.org/10.1016/s1875-5364(20)30020-0openalex-snapshot
Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice
inferred← citeshttps://doi.org/10.1016/s2468-1253(19)30326-7openalex-snapshot
The knowns and unknowns of treatment for alcoholic hepatitis
inferred← citeshttps://doi.org/10.1021/acs.jafc.8b05756openalex-snapshot
Inhibition of P2X7R–NLRP3 Inflammasome Activation by Pleurotus citrinopileatus: A Possible Protective Role in Alcoholic Hepatosteatosis
inferred← citeshttps://doi.org/10.1021/acs.jproteome.4c00451openalex-snapshot
Multiomics Studies on Metabolism Changes in Alcohol-Associated Liver Disease
inferred← citeshttps://doi.org/10.1038/cmi.2015.115openalex-snapshot
NKT cell subsets as key participants in liver physiology and pathology
inferred← citeshttps://doi.org/10.1038/icb.2016.107openalex-snapshot
Hypoxic modulation of hepatocyte responses to the cytokine interleukin‐22
inferred← citeshttps://doi.org/10.1038/jid.2014.5openalex-snapshot
Genetic Variants of the IL22 Promoter Associate to Onset of Psoriasis before Puberty and Increased IL-22 Production in T Cells
inferred← citeshttps://doi.org/10.1038/nprot.2013.032openalex-snapshot
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
inferred← citeshttps://doi.org/10.1038/nrd4176openalex-snapshot
Therapeutic opportunities of the IL-22–IL-22R1 system
inferred← citeshttps://doi.org/10.1038/nrgastro.2011.134openalex-snapshot
Alcoholic liver disease: pathogenesis and new targets for therapy
inferred← citeshttps://doi.org/10.1038/nrgastro.2012.225openalex-snapshot
Ischaemia–reperfusion injury in liver transplantation—from bench to bedside
inferred← citeshttps://doi.org/10.1038/nri3766openalex-snapshot
The IL-20 subfamily of cytokines — from host defence to tissue homeostasis
inferred← citeshttps://doi.org/10.1038/s41392-022-01149-xopenalex-snapshot
Signaling pathways in obesity: mechanisms and therapeutic interventions
inferred← citeshttps://doi.org/10.1038/s41419-022-05137-5openalex-snapshot
ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression
inferred← citeshttps://doi.org/10.1038/s41423-018-0029-8openalex-snapshot
Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects
inferred← citeshttps://doi.org/10.1038/s41423-020-00580-wopenalex-snapshot
Immunopathobiology and therapeutic targets related to cytokines in liver diseases
inferred← citeshttps://doi.org/10.1038/s41467-024-45568-6openalex-snapshot
Intestinal IL-22RA1 signaling regulates intrinsic and systemic lipid and glucose metabolism to alleviate obesity-associated disorders
inferred← citeshttps://doi.org/10.1038/s41575-020-00372-7openalex-snapshot
Molecular and cellular mechanisms of liver fibrosis and its regression
inferred← citeshttps://doi.org/10.1038/s41598-025-28718-8openalex-snapshot
IL-22 attenuates MAFLD progression by modulating oxidative stress and ferroptosis
inferred← citeshttps://doi.org/10.1038/srep35610openalex-snapshot
LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis
inferred← citeshttps://doi.org/10.1039/c8fo01227jopenalex-snapshot
Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver disease via IL-22-mediated JAK1/STAT3/BAX signaling
inferred← citeshttps://doi.org/10.1039/c9ra08976dopenalex-snapshot
Therapeutic potency of fermented field water-dropwort ( Oenanthe javanica (Blume) DC.) in ethanol-induced liver injury
inferred← citeshttps://doi.org/10.1039/d1fo03486copenalex-snapshot
Glucopyranose from Pleurotus geesteranus prevent alcoholic liver diseases by regulating Nrf2/HO-1-TLR4/NF-κB signalling pathways and gut microbiota
inferred← citeshttps://doi.org/10.1042/cs20140576openalex-snapshot
Interleukin-32γ attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses
inferred← citeshttps://doi.org/10.1042/cs20150405openalex-snapshot
The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice
inferred← citeshttps://doi.org/10.1042/cs20150591openalex-snapshot
Potent irreversible P2Y12 inhibition does not reduce LPS-induced coagulation activation in a randomized, double-blind, placebo-controlled trial
inferred← citeshttps://doi.org/10.1053/j.gastro.2011.06.051openalex-snapshot
A Proinflammatory Role for Interleukin-22 in the Immune Response to Hepatitis B Virus
inferred← citeshttps://doi.org/10.1053/j.gastro.2011.09.002openalex-snapshot
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
inferred← citeshttps://doi.org/10.1053/j.gastro.2012.03.044openalex-snapshot
Interleukin-22 Promotes Proliferation of Liver Stem/Progenitor Cells in Mice and Patients With Chronic Hepatitis B Virus Infection
inferred← citeshttps://doi.org/10.1053/j.gastro.2013.08.038openalex-snapshot
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
inferred← citeshttps://doi.org/10.1053/j.gastro.2013.11.008openalex-snapshot
Deletion of SIRT1 From Hepatocytes in Mice Disrupts Lipin-1 Signaling and Aggravates Alcoholic Fatty Liver
inferred← citeshttps://doi.org/10.1053/j.gastro.2014.10.042openalex-snapshot
Gut–Liver Axis in Alcoholic Liver Disease
inferred← citeshttps://doi.org/10.1053/j.gastro.2015.06.009openalex-snapshot
Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans
inferred← citeshttps://doi.org/10.1055/a-1714-9246openalex-snapshot
Inflammation in alcohol-associated liver disease progression
inferred← citeshttps://doi.org/10.1055/s-0037-1608788openalex-snapshot
Clinical Trial Design for Alcoholic Hepatitis
inferred← citeshttps://doi.org/10.1055/s-0042-119454openalex-snapshot
Etablierte Therapien und neue therapeutische Ansätze bei der alkoholischen Leberkrankung
inferred← citeshttps://doi.org/10.1073/pnas.2020868118openalex-snapshot
Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22
inferred← citeshttps://doi.org/10.1074/jbc.ra118.005739openalex-snapshot
Hepatitis B virus X protein–induced SH2 domain–containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5–transketolase interaction
inferred← citeshttps://doi.org/10.1080/00952990.2022.2128361openalex-snapshot
Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation
inferred← citeshttps://doi.org/10.1080/03007995.2018.1479247openalex-snapshot
Advances in the treatment of severe alcoholic hepatitis
inferred← citeshttps://doi.org/10.1080/08923973.2020.1799388openalex-snapshot
The double-edged role of IL-22 in organ fibrosis
inferred← citeshttps://doi.org/10.1080/08923973.2020.1810271openalex-snapshot
Amphiregulin alleviated concanavalin A-induced acute liver injury via IL-22
inferred← citeshttps://doi.org/10.1080/21655979.2022.2070998openalex-snapshot
RETRACTED ARTICLE: The amelioration of alcohol-induced liver and intestinal barrier injury by Lactobacillus rhamnosus Gorbach-Goldin (LGG) is dependent on Interleukin 22 (IL-22) expression
inferred← citeshttps://doi.org/10.1089/ars.2012.4756openalex-snapshot
In Vivo Consequence of Vitamin C Insufficiency in Liver Injury: Vitamin C Ameliorates T-Cell-Mediated Acute Liver Injury in Gulo(−/−) Mice
inferred← citeshttps://doi.org/10.1093/abbs/gmu097openalex-snapshot
FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway
showing the first 200 of 428 · page through all 428
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.